APA (7th ed.) Citation

C, F., FA, A., AQ, M., W, Z., L, L., G, Y., . . . W, C. (2022). Prognostic impact of coronary microvascular dysfunction assessed by caIMR in overweight with chronic coronary syndrome patients. Frontiers in endocrinology, 13, 922264. https://doi.org/10.3389/fendo.2022.922264

Chicago Style (17th ed.) Citation

C, Feng, et al. "Prognostic Impact of Coronary Microvascular Dysfunction Assessed by CaIMR in Overweight with Chronic Coronary Syndrome Patients." Frontiers in Endocrinology 13 (2022): 922264. https://doi.org/10.3389/fendo.2022.922264.

MLA (9th ed.) Citation

C, Feng, et al. "Prognostic Impact of Coronary Microvascular Dysfunction Assessed by CaIMR in Overweight with Chronic Coronary Syndrome Patients." Frontiers in Endocrinology, vol. 13, 2022, p. 922264, https://doi.org/10.3389/fendo.2022.922264.